Clinical Research Fellow in Translational Oncology
Disclaimer: Hunt UK Visa Sponsors aggregates job listings from publicly available sources, such as search engines, to assist with your job hunting. We do not claim affiliation with UCL. For the most up-to-date job details, please visit the official website by clicking "Apply Now."
About us
The UCL Cancer Institute (https://www.ucl.ac.uk/cancer/) is a state-of-the-art institute to consolidate cancer research at UCL and promote links with our partner teaching hospitals, in order to support excellence in basic and translational studies. The Treatment Resistance Team at the CI, led by Prof Gerhardt Attard, focuses on studying treatment resistance in advanced urological cancers and has been integrating circulating cell-free DNA, tumour tissues and single-cell technologies with functional studies to track tumour clone dynamics in patients progressing through multiple lines of treatment. Some of the group's work involves collecting biological samples from several trials, including STAMPEDE - a multi-arm, multistage, randomised-controlled platform trial that has recruited more than 10,000 patients since 2005.
University College London Hospitals NHS Foundation Trust (UCLH) is one of the most complex NHS trusts in the UK, serving a large and diverse population. We provide academically-led acute and specialist services, to people from the local area, from throughout the United Kingdom and overseas. Our vision is to deliver top-quality patient care, excellent education and world-class research.
We are dedicated to the diagnosis and treatment of many complex illnesses. UCLH specialises in women's health and the treatment of cancer, infection, neurological, gastrointestinal and oral disease. It has world class support services including critical care, imaging, nuclear medicine and pathology.
About the role
The main objective of this post will be to coordinate the collection, processing, and analysis of clinical, imaging and biopsy data from the ReIMAGINE study. As such, the postholder will hold honorary contracts across all ReIMAGINE sites (University College London Hospital, the Royal Free Hospital and Charing Cross Hospital). Overall responsibility for the postholder will be with the UCL Treatment Resistance Team. This appointment would suit foundation, core medical or core surgical trainees considering a career in oncology, urology, radiology or pathology or specialist trainees prior to undertaking a MD/PhD. We have a strong track record in helping trainees gain their subsequent chosen positions including national training numbers, consultant posts and industry roles. The post will be appointed on one of the scales including in the job description, depending on experience and is available for one year in the first instance.
The Treatment Resistance Team at the CI, led by Prof Gerhardt Attard, focuses on studying treatment resistance in advanced urological cancers and has been integrating circulating cell-free DNA, tumour tissues and single-cell technologies with functional studies to track tumour clone dynamics in patients progressing through multiple lines of treatment. Some of the group's work involves collecting biological samples from several trials, including STAMPEDE - a multi-arm, multistage, randomised-controlled platform trial that has recruited more than 10,000 patients since 2005.
Prospective candidates are encouraged to visit the UCLH and UCL Cancer Institute websites or premises. Further information can be obtained from Dr Vasilis Stavrinides () or Dr Matt Fittall ().
About you Successful candidate must have Undergraduate medical degree (MBBS or equivalent), completion of UK Foundation Training (or equivalent) and be eligible for full GMC Registration. Evidence of Good Clinical Practice training (or equivalent) is essential as is the ability to supervise junior staff and provide training as necessary. Prior experience in collecting, curating and interpreting clinical data would be desirable.
For rewards and benefits at UCL please visit: https://www.ucl.ac.uk/work-at-ucl/reward-and-benefits
You can read more about our commitment to Equality, Diversity and Inclusion here https://www.ucl.ac.uk/equality-diversity-inclusion/
Position
This appointment is for 1 year and would suit either Foundation, Core Medical or Core Surgical
Trainees considering a career in oncology, urology, radiology or pathology, or Urology, oncology,
pathology or radiology specialist trainees prior to undertaking a MD/PhD.
Copyright © 2025